Effect of Pharmacists Treating Diabetes in a FQHC
Diabetes Mellitus, Type 2
About this trial
This is an interventional treatment trial for Diabetes Mellitus, Type 2 focused on measuring pharmacist, diabetes, Preventative Care, Quality of Life
Eligibility Criteria
Inclusion Criteria:
- Age 18 and 74
- Medicaid insurance
- HbA1c of 8% or greater
Exclusion Criteria:
- HbA1C greater than 15% because the finger stick device can not accurately read values greater than this unless the HbA1C can be confirmed with a value drawn in the laboratory.
- Age < 18 years old or age ≥ 75 years old
HbA1c < 8.5% PLUS presence of one or more of the following regardless of age:
- Limited life expectancy
- History of severe hypoglycemia
HbA1c < 8.5% PLUS presence of one or more of the following if age ≥ 65 years old:
- Residency in a long-term care facility (e.g. nursing home, adult family home, etc.)
- ≥ 3 co-existing chronic illnesses c
- Impairments in ability to perform two or more instrumental activities of daily living d
- Mild, moderate, or severe cognitive impairment as determined by the patient's provider and Mini-Cog test
Sites / Locations
- Henry J Austin Health Clinic
Arms of the Study
Arm 1
Arm 2
No Intervention
Other
No intervention
Intervention group
The no intervention group will serve as control group. This group will receive standard care and will be an active comparator. At the end of the study they may join the intervention group
The intervention group will be seen by a pharmacist iin addition to their normal provider. The pharmacist will provide medication therapy review of the patient's therapy. The pharmacist will make recommendations to make revisions in the patient's therapy.